November 2025
The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlyCookie settingsWe may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.
Privacy policy
Revvity’s new automated free testosterone assay receives FDA clearance
, /in Product News /by panglobalRevvity Inc has announced FDA 510(k) clearance for EUROIMMUN’s automated chemilumin-escence immunoassay (ChLIA) for direct quantitative measurement of free testosterone. The assay, which runs on the company’s iSYS and i10 platforms, represents the first FDA-cleared automated direct measurement method for free testosterone in human serum or plasma.
Sapio Sciences expands laboratory informatics capabilities
, /in Product News /by panglobalLaboratory software provider Sapio Sciences has announced significant updates to its informatics platform, enhancing functionality across chemistry, immunogenicity, GMP workflows and molecular biology. Release 24.12 introduces automated validation tools and refined chemistry representation capabilities, aimed at improving laboratory efficiency and data management.
Thermo Fisher unveils DNA/RNA extraction kit for haematological cancer research
, /in Product News /by panglobalA new sequential DNA/RNA isolation kit has been launched by Thermo Fisher Scientific, designed to streamline genomic analysis workflows in haematological cancer research. The MagMAX Sequential DNA/RNA kit enables concurrent extraction of DNA and RNA from a single sample, potentially accelerating research into blood-based malignancies.
Serum Amyloid A (SAA) nephelometric and turbidimetric assays
, /in Product News /by panglobalTRIMERO Diagnostics offers assays for testing Serum Amyloid A (SAA) on Beckman Coulter’s IMMAGE® Immunochemical Systems and Clinical Chemistry Analyzers.
Johnson & Johnson acquires lumateperone developer in £14.6bn deal
, /in E-News /by panglobalJohnson & Johnson (J&J) has announced the acquisition of Intra-Cellular Therapies for $14.6 billion, marking a significant expansion of its neuroscience portfolio. The deal centres on CAPLYTA (lumateperone), a novel antipsychotic with a distinctive pharmacological profile characterised by high serotonin 5-HT2A receptor occupancy combined with lower dopamine D2 receptor binding at therapeutic doses.
PrecisionLife advances diagnostic strategy with new chief commercial officer appointment
, /in E-News /by panglobalPrecisionLife has appointed Bill Keating as chief commercial officer for diagnostics and healthcare, marking a significant step in the company’s expansion of its Mechanostic testing platform for complex chronic diseases. The Oxford-based precision medicine company announced the appointment on 8 January 2025, signalling an intensified focus on commercialising its non-invasive genotypic testing capabilities.
Revvity partners with Element Biosciences to develop sequencing-based IVD neonatal screening
, /in E-News /by panglobalRevvity Inc. has announced a strategic partnership with Element Biosciences Inc. to develop and commercialise an in vitro diagnostic (IVD) workflow solution for neonatal sequencing. The collaboration builds upon Revvity’s existing next-generation sequencing (NGS) workflow for newborn sequencing research and aims to strengthen Element’s regulatory approval pathway for their AVITI benchtop sequencing system.
Roche acquires allogeneic CAR-T developer Poseida Therapeutics for $1.5bn
, /in E-News /by panglobalRoche has announced a definitive merger agreement to acquire the San Diego-based clinical-stage biopharmaceutical company Poseida Therapeutics, marking a significant expansion of its cell therapy portfolio. The acquisition, valued at up to US$1.5 billion, builds upon an existing partnership established in 2022 and aims to accelerate the development of off-the-shelf CAR-T cell therapies.
Leica Biosystems invests in Indica Labs to advance AI-powered digital pathologyIBA Lifesciences acquisition
, /in E-News /by panglobalLeica Biosystems has announced a significant strategic investment in artificial intelligence (AI) specialist Indica Labs, marking a pivotal advancement in digital pathology. The collaboration, announced on 8 January 2025, aims to accelerate the development of AI-enabled companion diagnostics (CDx) and enhance the detection of complex biomarker expression profiles that exceed human visual capabilities.
Beckman Coulter modernises South West London Pathology diagnostic capabilities with advanced laboratory installation
, /in E-News /by panglobalSouth West London Pathology (SWLP) has initiated a comprehensive modernisation of its clinical blood science services, beginning with the installation of state-of-the-art analysers at Croydon Hospital. This development marks the first phase of a broader implementation strategy across the SWLP network, encompassing clinical chemistry, haematology, coagulation, serology, and pre-analytical automation systems.